Mudit K. Jain, Ph.D . has served as a director on the Board since July 2020. He has served as a Founding General Partner at Treo Ventures, a medical device-focused venture capital firm, since September 2018, and previously served as a Managing Director at Synergy Venture Partners, LLC, a medical technology venture capital investment firm, from April 2007 to September 2018. Dr. Jain has also served as the CEO and co-founder of NuXcel, a medical device accelerator, since 2018, and has founded four neuromodulation companies-ShiraTronics, Inc., Avivmed, Inc., iVEAcare, Inc., and iRiva Medical, Inc. Dr. Jain currently serves on the boards of directors of Avivomed, Inc., Neochord, Inc., Neuspera, Inc., SecondWave Systems, Inc., iRiva Medical, Inc., NuXcel, ShiraTronics, Inc., and iVEAcare, Inc., and he previously served on the board of directors of Inspire Medical Systems, Inc., Aptus Endosystems, Inc., and Impres Medical, Inc. Dr. Jain received a Ph.D. in Biomedical Engineering from Duke University, an M.B.A. from The Wharton School of the University of Pennsylvania and a B.E. in Electrical Engineering from National Institute of Technology, Nagpur, India. The Board believes that Dr. Jain s experience as a venture capital investor and expertise in biomedical engineering qualify him to serve as a director on the Board.